ConductScience.org, home

Paper7878469

Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.

Jeffrey PD and 2 others. Science, 1995. Cited by 458 papers, by iCite.

Cite this record

ConductScience Library. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Papers, record 7878469. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7878469

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
PubMed
Journal
Science
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
458
iCite
Relative citation ratio, by iCite
8.44
iCite
Revised in PubMed
2019-06-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jeffrey PDP D
2Gorina SS
3Pavletich NPN P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein ConformationMajor topic
Tumor Suppressor Protein p53Major topic
Computer Graphics
Crystallography, X-Ray
DNA
Hydrogen Bonding
Macromolecular Substances
Models, Molecular
Protein Structure, Secondary

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA08748-29NCI NIH HHSUnited StatesPubMedPubMed
P01CA008748NIHNIH RePORTER
P30CA008748NIHNIH RePORTER

Download CSV of grants

Cited by212

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 458 citations.

PMIDTitleJournalYearIn PapersSource
42432287Revisiting the p53:Sirt1 interaction in light of controlling p53 acetylation levels.Commun Chem2026https://conductscience.org/library/papers/42432287PubMed
42311239Biology of p53 protein isoforms and their significance in hematological malignancies.Front Oncol2026https://conductscience.org/library/papers/42311239PubMed
42143149Cancer-linked aggregation of p53 is driven by sequence-encoded frustration, solvation, and hydrophobic gating absent in its paralogs.Commun Chem2026https://conductscience.org/library/papers/42143149PubMed
41917811Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies.Cell Mol Biol Lett2026https://conductscience.org/library/papers/41917811PubMed
41807394CF2H: a cell-free two-hybrid platform for rapid protein binder screening.Nat Commun2026https://conductscience.org/library/papers/41807394PubMed
41764184Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification.Cell Death Dis2026https://conductscience.org/library/papers/41764184PubMed
41688727The TP53 gene contains a diversity box that makes it more than a tumor suppressor.Cell Death Differ2026https://conductscience.org/library/papers/41688727PubMed
41683580Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer-A Comprehensive Review of Literature.Int J Mol Sci2026https://conductscience.org/library/papers/41683580PubMed
41552434Restoration of the Y220C p53 Full-Length Mutant by PK11000: a Molecular Dynamics Study of an Intrinsically Disordered Protein.ACS Omega2026https://conductscience.org/library/papers/41552434PubMed
40704418Dominant-Negative Effects of p53 R337 Variants in Li-Fraumeni Syndrome: Impact on Tetramer Formation and Transcriptional Activity.Chembiochem2025https://conductscience.org/library/papers/40704418PubMed
40690375Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation.Elife2025https://conductscience.org/library/papers/40690375PubMed
40334261Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.PLoS One2025https://conductscience.org/library/papers/40334261PubMed
40233742Integration of protein stability and AlphaMissense scores improves bioinformatic impact prediction for p53 missense and in-frame amino acid deletion variants.Am J Hum Genet2025https://conductscience.org/library/papers/40233742PubMed
40233741Structural biology in variant interpretation: Perspectives and practices from two studies.Am J Hum Genet2025https://conductscience.org/library/papers/40233741PubMed
40001547The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations.Biomolecules2025https://conductscience.org/library/papers/40001547PubMed
39944631Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53.Front Pharmacol2025https://conductscience.org/library/papers/39944631PubMed
39634561Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.iScience2024https://conductscience.org/library/papers/39634561PubMed
39520074The Ashkenazi-Centric G334R Variant of TP53 is Severely Impaired for Transactivation but Retains Tumor Suppressor Function in a Mouse Model.Mol Cell Biol2024https://conductscience.org/library/papers/39520074PubMed
39309126Navigating the complexity of p53-DNA binding: implications for cancer therapy.Biophys Rev2024https://conductscience.org/library/papers/39309126PubMed
39294166Germline variant affecting p53β isoforms predisposes to familial cancer.Nat Commun2024https://conductscience.org/library/papers/39294166PubMed

See all 212 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157Swiss-Prot's referenceshttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7878469

GET https://conductscience.org/api/papers/v1/7878469/cited_by?page=2